Copeptin-based diagnosis of diabetes insipidus

Review article: Biomedical intelligence
Refardt J, Christ-Crain M
Swiss Med Wkly. 2020;150:w20237

With the establishment of copeptin, a stable and reliable surrogate marker for arginine vasopressin, diagnosis of the polyuria-polydipsia syndrome has been newly evaluated.

Supplementum 242: Abstracts of the 51st Annual meeting of the Swiss Society of Nephrology

Supplement
Swiss Med Wkly. 2019;149:w20339

Use of day and night urinary iodine excretion to estimate the prevalence of inadequate iodine intakes via the estimated average requirement cut-point method

Original article
Stalder E, Haldimann M, Blanc A, Dudler V, Ponte B, Pruijm M, Ackermann D, Bochud M
Swiss Med Wkly. 2019;149:w20090

Segregating 24-hour urine into day and night collections is sufficient to determine the prevalence of iodine inadequacy in the population.

Reality check: primary vascular access creation today

Original article
Jann T, Wyss TR, Gahl B, Kalicki RM, Uehlinger DE, Widmer MK
Swiss Med Wkly. 2018;148:w14668

In Switzerland, the outcome of vascular access creation in the 4500 patients on dialysis is unknown, mainly because there is no prospective registry for patients undergoing vascular access surgery for renal replacement therapy.

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials

Systematic review
Mavrakanas TA, Aurian-Blajeni DE, Charytan DM
Swiss Med Wkly. 2017;147:w14507

Pre-emptive dialysis could theoretically improve outcomes in critically ill patients, but might expose patients who would shortly recover enough renal function to stay off dialysis to dialysis-related complications.

Early complications after living donor nephrectomy: analysis of the Swiss Organ Living Donor Health Registry

Original article
Burkhalter F, Huynh-Do U, Hadaya K, Matter M, Müller T, Binet I, Nolte C, Steiger J
Swiss Med Wkly. 2017;147:w14497

Despite the increase of living kidney donation during past decades there are only a few articles reporting prospectively collected cohort data about perioperative, short-term and long-term complications after living donor nephrectomy.

Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices

Original article
Corcillo A, Pivin E, Lalubin F, Pitteloud N, Burnier M, Zanchi A
Swiss Med Wkly. 2017;147:w14459

Specific goals for blood glucose, blood pressure and lipid control have been defined for diabetes patients. Primary care physicians have difficulty in reaching all goals, as time dedicated to the care of patients in an outpatient setting is confined.

Changing trends in end-stage renal disease patients with diabetes

Original article
Lu Y, Stamm C, Nobre D, Pruijm M, Teta D, Cherpillod A, Halabi G, Phan O, Fumeaux Z, Bullani R, Gauthier T, Mathieu C, Burnier M, Zanchi A
Swiss Med Wkly. 2017;147:w14458

An understanding of the epidemiology of diabetic nephropathy, which varies between countries, is of great importance to the development and implementation of prevention and management strategies.

Diagnosis and assessment of renal fibrosis: the state of the art

Review article: Biomedical intelligence
Berchtold L, Friedli I, Vallée JP, Moll S, Martin PY, de Seigneux S
Swiss Med Wkly. 2017;147:w14442

Evaluation of interstitial fibrosis is crucial to the assessment of prognosis and to guide therapy for most kidney diseases. However, how best to measure kidney fibrosis remains uncertain.

Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs

Original article
Lamine F, Lalubin F, Pitteloud N, Burnier M, Zanchi A
Swiss Med Wkly. 2016;146:w14282